FI69099C - Foerfarande foer framstaellning av farmaceutiskt aktiv kijanimicin - Google Patents

Foerfarande foer framstaellning av farmaceutiskt aktiv kijanimicin Download PDF

Info

Publication number
FI69099C
FI69099C FI810078A FI810078A FI69099C FI 69099 C FI69099 C FI 69099C FI 810078 A FI810078 A FI 810078A FI 810078 A FI810078 A FI 810078A FI 69099 C FI69099 C FI 69099C
Authority
FI
Finland
Prior art keywords
kijanimicin
absent
dfp
actinomadura
agar
Prior art date
Application number
FI810078A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI810078L (fi
FI69099B (fi
Inventor
Jay Allan Waitz
Ann Camille Horan
Mahesh Gordhandas Patel
Original Assignee
Essex Laeaekkeet Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Essex Laeaekkeet Oy filed Critical Essex Laeaekkeet Oy
Publication of FI810078L publication Critical patent/FI810078L/fi
Publication of FI69099B publication Critical patent/FI69099B/sv
Application granted granted Critical
Publication of FI69099C publication Critical patent/FI69099C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03Actinomadura
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI810078A 1980-01-17 1981-01-13 Foerfarande foer framstaellning av farmaceutiskt aktiv kijanimicin FI69099C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11276080A 1980-01-17 1980-01-17
US11276080 1980-01-17
US19504880 1980-10-08
US06/195,048 US4375542A (en) 1980-01-17 1980-10-08 Kijanimicin antibiotics and derivatives thereof

Publications (3)

Publication Number Publication Date
FI810078L FI810078L (fi) 1981-07-18
FI69099B FI69099B (fi) 1985-08-30
FI69099C true FI69099C (fi) 1985-12-10

Family

ID=26810312

Family Applications (1)

Application Number Title Priority Date Filing Date
FI810078A FI69099C (fi) 1980-01-17 1981-01-13 Foerfarande foer framstaellning av farmaceutiskt aktiv kijanimicin

Country Status (20)

Country Link
US (1) US4375542A (ja)
EP (1) EP0033840B1 (ja)
JP (1) JPS56118078A (ja)
KR (1) KR840000751B1 (ja)
AR (1) AR226337A1 (ja)
AT (1) ATE8798T1 (ja)
AU (1) AU543520B2 (ja)
CA (1) CA1177426A (ja)
DE (1) DE3164568D1 (ja)
DK (1) DK149823C (ja)
ES (1) ES498452A0 (ja)
FI (1) FI69099C (ja)
HU (1) HU181799B (ja)
IE (1) IE50810B1 (ja)
IL (1) IL61902A (ja)
NO (1) NO155732C (ja)
NZ (1) NZ196006A (ja)
PH (1) PH17057A (ja)
PT (1) PT72348B (ja)
ZA (1) ZA81217B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983525A (en) * 1987-07-02 1991-01-08 American Cyanamid Company Plasmids derived from actinomadura species
US5753701A (en) * 1996-10-25 1998-05-19 University Of Kentucky N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters as novel safe agents for water disinfection
CA2342325A1 (en) 1998-08-31 2000-03-09 Kyowa Hakko Kogyo Co., Ltd. An agent for inducing apoptosis
DE60136067D1 (de) * 2000-04-26 2008-11-20 Meiji Seika Kaisha Gemische zur behandlung oder prävention von malaria und verfahren zur behandlung von malaria
AU2002330374A1 (en) * 2001-11-22 2003-06-10 Kazuo Shinya Novel tetronic acid dervative
US8754054B2 (en) 2010-07-09 2014-06-17 Albany Molecular Research, Inc. Antibacterial compounds, methods of making them, and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364113A (en) * 1962-04-23 1968-01-16 Westminster Lab Ltd Senna preparations and methods of making and using them
FR1530409A (fr) * 1963-08-28 1968-06-28 Nouveaux dérivés de l'asiaticoside et leur procédé de préparation
US3723410A (en) * 1970-12-01 1973-03-27 Amazon Natural Drug Co Method of producing stevioside
JPS51142570A (en) * 1975-06-04 1976-12-08 Morita Kagaku Kogyo Method of imparting sweetness to food or pharmaceutical agent

Also Published As

Publication number Publication date
ES8200922A1 (es) 1981-11-16
HU181799B (en) 1983-11-28
KR830005360A (ko) 1983-08-13
FI810078L (fi) 1981-07-18
ES498452A0 (es) 1981-11-16
DK149823B (da) 1986-10-06
NO155732C (no) 1987-05-20
JPH0327559B2 (ja) 1991-04-16
KR840000751B1 (ko) 1984-05-31
AU6619181A (en) 1981-07-23
PH17057A (en) 1984-05-17
DE3164568D1 (en) 1984-09-06
IE50810B1 (en) 1986-07-23
DK149823C (da) 1987-03-16
FI69099B (fi) 1985-08-30
AR226337A1 (es) 1982-06-30
EP0033840A3 (en) 1981-12-02
AU543520B2 (en) 1985-04-26
CA1177426A (en) 1984-11-06
NO155732B (no) 1987-02-09
DK12581A (da) 1981-07-18
IL61902A (en) 1984-10-31
IL61902A0 (en) 1981-02-27
EP0033840A2 (en) 1981-08-19
NZ196006A (en) 1983-09-02
ATE8798T1 (de) 1984-08-15
PT72348B (en) 1981-12-18
IE810054L (en) 1981-07-17
ZA81217B (en) 1982-01-27
US4375542A (en) 1983-03-01
PT72348A (en) 1981-02-01
NO810114L (no) 1981-07-20
EP0033840B1 (en) 1984-08-01
JPS56118078A (en) 1981-09-16

Similar Documents

Publication Publication Date Title
Takiguchi et al. Milbemycins, a new family of macrolide antibiotics: fermentation, isolation and physico-chemical properties
CA1220149A (en) Rebeccamycin and process for its preparation
US4518589A (en) BBM-2478 Antibiotic complex
NO148959B (no) Fremgangsmaate ved fremstilling av tumor-motvirkende antracyklinglykosidantibiotika, betegnet ma 144
US5510372A (en) Antiparasitic macrolide antiobiotics
KR900006233B1 (ko) 폴리사이클릭 에테르 항생물질의 제조방법
FI69099C (fi) Foerfarande foer framstaellning av farmaceutiskt aktiv kijanimicin
Slechta et al. Isolation and characterization of a new antibiotic U-62162
EP0350623A2 (en) BU-3420T antitumor antibiotic
US4869901A (en) Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents
EP0110155B1 (en) Novel anthracycline derivatives, a process for preparing the same by a microorganism strain, the novel strain streptomyces cyaneus, and use of the anthracycline derivatives as medicaments
US5521169A (en) Ascosteroside and analogs thereof useful in antifungal compositions for methods of treating infections and inhibition of fungal growth
EP1001957B1 (en) Macrolides with antitumor activity
EP0871638A1 (en) Novel aminooligosaccharide derivative and process for preparing the same
EP0033433A1 (en) Macrolide antibiotics, process for their preparation, inter alia by fermentation, and pharmaceutical compositions containing them
US4743594A (en) Antibiotic, antitumor compounds and their use
US5024950A (en) Actinomadura fulva subsp indica
JPS6235755B2 (ja)
US4904644A (en) Antimicrobial compound isolated from Actinomadura fulva subsp indica
US5420261A (en) Glycosides of 3'-deoxyaquayamycin antibiotics
KR890000405B1 (ko) 아버멕틴 및 밀베마이신 유도체의 제조방법
US4912133A (en) BU-3862T antitumor antibiotic
JPH0578322A (ja) 新規抗生物質sf2738物質及びその製造法並びに制癌剤
JPH0515385A (ja) 新規な抗生物質アリサマイシンおよびその製法
IE54813B1 (en) Microorganism actinomadura yumaense sp.nov. and use thereof to prepare antibiotics ll-c23024 alpha, beta and iota

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ESSEX LAEAEKKEET OY